GlassScriptPhysician profile
Joyce Cheryl Davis
NPI 1316977572
$1,741.65
in general payments reported to CMS, 2019-2025
20 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $191 · 2021: $284 · 2022: $196 · 2023: $181 · 2024: $391 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $299.98 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $257.46 | 2019-2024 | Aklief, Twyneo, Oracea |
| Allergan, INC. | $207.03 | 2019-2021 | |
| Abbvie INC. | $164.07 | 2023-2025 | Botox |
| Pfizer INC. | $157.54 | 2020-2022 | |
| Merz North America, INC. | $107.79 | 2020-2024 | Xeomin |
| Novartis Pharmaceuticals Corporation | $88.03 | 2021-2022 | |
| Incyte Corporation | $85.53 | 2022-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $62.84 | 2019-2021 | |
| Almirall LLC | $60.72 | 2020-2023 | Seysara |
| Leo Pharma INC. | $54.27 | 2024-2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $36.04 | 2021-2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $29.26 | 2020-2024 | Clear+Brilliant |
| Genzyme Corporation | $24.98 | 2020 | |
| Stemline Therapeutics INC. | $23.03 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $20.27 | 2025 | Sofdra |
| Mayne Pharma Commercial LLC | $18.58 | 2021 | |
| Fidia Pharma USA INC. | $16.03 | 2024 | |
| Epi Health, LLC | $15.47 | 2021 | |
| Amgen INC. | $12.73 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.